CompletedNot Applicable

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Czechia123 participantsStarted 2021-10-15

Plain-language summary

The study series consists of three studies with the aim to assess the incidence, prevalence, risk factors, comorbidities and management of patients with alopecia areata in Czech Republic based on the patients and registry of a dermatology clinic of a metropolitan hospital.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients visiting our clinic with a dermatologic condition between 1/1/2011-31/12/2020 * For the second study, only patients with histologic/dermatoscopic diagnosis of new-onset/relapsing/peristent-untreated alopecia areata, presenting to our clinic between 15/10/2021-14/10/2022 are included. Exclusion Criteria: * For the second study patients with other alopecias, patients denying data sharing despite signing the informed concent and presenting outside the study period are excluded. * For the third study, patients with other types of alopecia, as well as those who signed the informed consent but refused to share their data or undergo blood tests at our hospital, and those who did not visit our outpatient department at least once a month for the required duration, were excluded.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The epidemiology of Alopecia areata

Timeframe: 1/1/2011-31/12/2020

The epidemiology of Alopecia areata

Timeframe: 1/10/2020-30/9/2021

Prevalence of atopic and autoimmune conditions in patients with Alopecia Areata

Timeframe: 15/10/2021-14/10/2022

Treatments for alopecia areata

Timeframe: 15/10/2021-14/10/2022

Safety and efficacy of treatments in alopecia areata

Timeframe: 15/10/2021-14/10/2022

Measurement of Thyroid stimulating hormone (TSH)

Timeframe: 15/10/2021-14/10/2022

Measurement of free Thyroxine (fT4)

Timeframe: 15/10/2021-14/10/2022

Trial details

NCT IDNCT05098600

SponsorFaculty Hospital Kralovske Vinohrady

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2022-10-14

View on ClinicalTrials.gov More Alopecia Areata trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

The epidemiology of Alopecia areata

Timeframe: 1/1/2011-31/12/2020

The epidemiology of Alopecia areata

Timeframe: 1/10/2020-30/9/2021

Prevalence of atopic and autoimmune conditions in patients with Alopecia Areata

Timeframe: 15/10/2021-14/10/2022

Treatments for alopecia areata

Timeframe: 15/10/2021-14/10/2022

Safety and efficacy of treatments in alopecia areata

Timeframe: 15/10/2021-14/10/2022

Measurement of Thyroid stimulating hormone (TSH)

Timeframe: 15/10/2021-14/10/2022

Measurement of free Thyroxine (fT4)

Timeframe: 15/10/2021-14/10/2022